News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
249
Sources here
18
Companies here
11
Search results Stored financial headlines

Active search

249 matching headlines

Ticker or company: OSMMain company stories
Clear
Latest

finance.yahoo.com Deals and strategy

PROYA Partners with Ulta Beauty: Joining The Retailer's Prestige Skincare Portfolio Later This Year

HANGZHOU, China, Aug. 19, 2026 /PRNewswire/ -- PROYA, the flagship brand of Proya Cosmetics, has partnered with Ulta Beauty, the nation's largest beauty retailer. PROYA will join Ulta Beauty as part of the retailer's global prestige skincare lineup. This November, PROYA will officially launch its Advanced Firming and Original Repair collections in 400 Ulta Beauty stores nationwide and …

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Kosmos Energy Ltd. stock rises Tuesday, outperforms market

Kosmos Energy Ltd. (KOS) saw its stock price increase by 5.38% to $2.74 on Tuesday, defying a general market downturn where the NASDAQ Composite and Dow Jones Industrial Average both fell. This marks the fourth consecutive day of gains for Kosmos Energy.

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GSK plc (NYSE: GSK) execs add ADS via dividend plans on Aug. 14

GSK plc reported that several senior personnel acquired American Depositary Shares (ADS) on August 14, 2026, through dividend reinvestment plans. Dr. Hal Barron, James Ford, and Maya Martinez-Davis each added notional ADS or ADS at a price of $49.5200 per ADS on the New …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kosmos Energy Ltd. stock rises Monday, outperforms market

Kosmos Energy Ltd. (KOS) stock increased by 2.36% to $2.60 on Monday, outperforming the broader market which saw declines in the NASDAQ Composite Index and Dow Jones Industrial Average. This marked the third consecutive day of gains for Kosmos Energy Ltd.

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Profit Rebound and Portfolio Shift Could Be A Game Changer For Kosmos Energy (KOS)

Kosmos Energy (KOS) reported strong second-quarter 2026 results with a significant profit rebound and increased production, driven by ramp-ups at GTA and new Jubilee wells. This performance, along with updated production guidance, supports the company's near-term growth narrative despite ongoing risks associated with its …

KOS main company KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cosmos Health Inc. SEC Filing (Aug 14, 2026)

Cosmos Health Inc. (COSM) has filed a Form 12b-25 Notification of Late Filing, indicating that it will not be able to file its Quarterly Report on Form 10-Q for the period ended June 30, 2026, on time. The delay is attributed to difficulties in …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cosmos Health Inc expected to post earnings of 1 cent a share - Earnings Preview

Cosmos Health Inc is anticipated to report earnings of 1 cent per share. This article provides an earnings preview for the company. Access to the full Reuters article is available through a TradingView subscription.

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GSK plc (GSK) 13F filing lists 13 U.S. positions worth over $602M

GSK plc has filed a Form 13F Holdings Report, disclosing 13 U.S. securities positions with a total aggregate value of $602,220,442. This filing indicates that GSK plc is the sole institutional investment manager responsible for these holdings, with no other managers included in the …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum. The firm's total Q2 turnover reached £8.4 billion, marking a 5% increase year-over-year at constant exchange rates (CER), while Core operating profit climbed …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dodge & Cox reports 4.3% GSK plc (GSK) stake in Schedule 13G/A

Dodge & Cox, an investment manager, has reported a 4.3% beneficial ownership stake in GSK plc, as detailed in an Amendment No. 3 to Schedule 13G filing. The filing indicates that Dodge & Cox beneficially owns 76,864,040 Ordinary Shares and 48,197,514 American Depositary Shares, …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MFS Blended Research International Equity Fund's GSK PLC(LSE:GSK) Holding History

MFS Blended Research International Equity Fund holds 1.57 million shares of GSK PLC (LSE:GSK), valued at £39.86 million, representing 0.85% of their portfolio. The fund acquired these shares at an average price of £20.07, and based on the current price of £18.57, has an …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Senior GSK plc (GSK) leaders acquire Ordinary Shares through Share Reward Plan

Several senior leaders and one closely associated person at GSK plc acquired Ordinary Shares under the company's Share Reward Plan on August 11, 2026. The acquisitions were made on the London Stock Exchange at a price of £19.3496 per share, with most individuals acquiring …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Kosmos Energy (KOS) a Great Value Stock Right Now?

Zacks Investment Research highlights Kosmos Energy (KOS) as a strong value stock, giving it a Zacks Rank #2 (Buy) and an A grade for Value. The article points to KOS's attractive P/B ratio of 0.79 and P/S ratio of 0.96, both favorable compared to …

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kosmos Energy Ltd. stock falls Wednesday, underperforms market

Kosmos Energy Ltd. (KOS) stock decreased by 1.95% on Wednesday, closing at $2.51. This performance lagged behind the overall market, with the NASDAQ Composite Index rising and the Dow Jones Industrial Average slightly falling. The decline ended a four-day winning streak for Kosmos Energy.

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to earnings forward of Cosmos Health Inc – DUS:V67A

This article provides financial data for Cosmos Health Inc (DUS:V67A) on the Dusseldorf Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It presents a data table with period values and changes, noting that the market is currently closed with no trades. The content …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GSK plc (GSK) president reports acquisition of notional ADS in savings plan

GSK plc reported that its President, Maya Martinez-Davis, acquired 9.016 notional American Depositary Shares (ADS) at $52.9600 per ADS on August 7, 2026. This transaction occurred on the New York Stock Exchange and was part of her GSK Executive Supplemental Savings Plan account. The …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kosmos Energy (KOS) Q2 2026 Earnings Call Transcript

Kosmos Energy discussed its Q2 2026 results, highlighting significant progress against its 2026 goals, including increased production from Jubilee and GTA, reduced operating costs, and a meaningful reduction in net debt. The company provided updates on its Ghana, GTA, and Gulf of America operations, …

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SCA secures US contract award with Kosmos Energy for an onshore umbilical storage carousel

Subsea Cable Assets (SCA) has won its first contract with Kosmos Energy to supply a newly designed 1000 t onshore umbilical storage carousel. This system will support umbilical storage and handling operations for an onshore project in Mobile, Alabama, USA, with delivery scheduled for …

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GSK Plc (GSK) Stock Analysis: Exploring A 9.66% Potential Upside In The Healthcare Giant

GSK Plc (GSK) shows a potential upside of 9.66% with a market capitalization of $106.07 billion and a forward P/E of 10.31, suggesting potential undervaluation. The company exhibits strong financial health with 5.30% revenue growth, a 33.38% ROE, and a 3.43% dividend yield. Analysts …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context